COMMUNIQUÉS West-GlobeNewswire

Diffusion Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
08/08/2019
Company Completes $6.28 Million Registered Direct Offering Favorable Data Reported in Glioblastoma Multiforme Phase 3 Run-in Study Phase 2 On-Ambulance TSC Clinical Trial for the Treatment of Stroke Ready to Enroll [...]
Theratechnologies Regains Control Over Distribution Rights to EGRIFTA® Worldwide
08/08/2019
MONTREAL, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that it has regained complete control over distribution rights of EGRIFTA ® worldwide, following [...]
Theratechnologies reprend le contrôle des droits de distribution d’EGRIFTA(MD) à l’échelle mondiale
08/08/2019
MONTRÉAL, 08 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’elle regagne le contrôle entier des droits de distribution d’ EGRIFTA MD à l’échelle mondiale, à [...]
Amarin Announces FDA Notification of Advisory Committee Meeting Planned to be Held in November 2019 in Connection With Vascepa® REDUCE-IT™ sNDA
08/08/2019
PDUFA Date Extension to End of December 2019 Expected Management to Host Conference Call Today at 7:00 p.m. ET BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN [...]
Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
08/08/2019
NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates
08/08/2019
Company is exploring potential strategic opportunities and non-dilutive sources of capital, and partnerships Continued activities of the first Phase 3 clinical trial for celiac disease including the screening and [...]
Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
08/08/2019
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the second quarter ended June 30, 2019 and provided a business update. Dr. Dennis J. [...]
AnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates
08/08/2019
Multiple Top-line Phase 2 Clinical Efficacy Readouts from Wholly-owned Pipeline Anticipated in 2019 Etokimab Phase 2b Eosinophilic Asthma Trial Initiation Anticipated in 4Q19 IND Filing for Company’s Third Wholly-Owned [...]
Agile Therapeutics Announces Full Exercise of Over-Allotment Option by Underwriters
08/08/2019
PRINCETON, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the underwriters of its previously announced public offering of common stock [...]
Zafgen Reports Second Quarter 2019 Operating and Financial Results
08/08/2019
Agreement reached with U.S. FDA on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study expected by the end of [...]
Homology Medicines Reports Second Quarter 2019 Financial Results and Recent Highlights
08/08/2019
- Phase 1/2 pheNIX Study of HMI-102 Gene Therapy Candidate for Adults with PKU Continues, Additional Sites Enrolling and Initial Data Expected by Year End - - Fast Track Designation Granted in the U.S. for HMI-102, [...]
Aravive Announces Executive Management Transition Plan
08/08/2019
CEO Jay Shepard to step down from his current role after a successor is appointed HOUSTON, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments [...]
Spero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline Update
08/08/2019
SPR994 pivotal Phase 3 cUTI trial enrollment continues; multiple clinical pipeline catalysts expected in 2H19 CAMBRIDGE, Mass., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset [...]
Zomedica Announces Second Quarter 2019 Financial Results
08/08/2019
ANN ARBOR, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]
Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results
08/08/2019
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial results for the three [...]
Cytokinetics Reports Second Quarter 2019 Financial Results
08/08/2019
Completed Enrollment in GALACTIC-HF with More than 8,200 Heart Failure Patients Results from Phase 1 Study of CK-274 to be Presented at HFSA in September 2019; Phase 2 Clinical Trial Expected to Begin in Q4 SOUTH SAN [...]
BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations
08/08/2019
BELBUCA® Net Sales Increased 147% versus Prior Year to All-Time High of $24.1 Million Raises Full-Year BELBUCA Net Sales Expectations to $90 - $93 Million Raises Full-Year Total Company Net Sales Expectations to $101 [...]
Cerecor Reports Second Quarter 2019 Results
08/08/2019
-Positive Final Results with CERC-301 in nOH -First Patient Enrolled in CDG FIRST Trial - FDA Acceptance of IND Application of CERC-802 ROCKVILLE, Md., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a [...]
BeiGene Reports Second Quarter 2019 Financial Results
08/08/2019
CAMBRIDGE, Mass. and BEIJING, China, Aug. 08, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages